Contact us today to discuss your preclinical needs. Our team delivers tailored solutions, transparent timelines, and competitive pricing to keep your pipeline moving forward.
Preclinical Drug Development Solutions
Preclinical Drug Development Solutions
Pharmacodynamic Evaluation
Large Animal Models
Myocardial infarction (pig), diabetes (NHP), stroke (dog), and more.
Small Animal Model
Xenograft tumors, Alzheimer’s (transgenic mice), and inflammation.
Pharmacokinetics & Toxicology (DMPK)
In Vitro Studies
Caco-2 permeability, CYP induction/inhibition, metabolite profiling.
In Vivo ADME
Full PK/PD profiling in rodents, rabbits, and non-human primates.
Toxicokinetics
Dose-range finding and safety margin analysis.
GLP Safety Assessment
Acute/Chronic Toxicity
Genotoxicity, Carcinogenicity
Cardiovascular (hERG) & Respiratory Safety
Biomarker-Driven Risk Mitigation
SPF & Conventional Animal Housing
Imaging & Surgery Suites
Molecular & Pathology Labs
Why Partner with HuaTeng Biotechnology?
Full-Service Expertise: Efficacy, pharmacokinetics (PK/PD), and safety studies under one roof
Globally Accredited Labs: GLP-compliant facilities aligned with OECD, FDA, and NMPA standards
Advanced Infrastructure: SPF-grade animal housing, laminar flow labs, CT/micro-CT imaging, and automated analytics
Species Diversity: Large (NHP, dogs, minipigs) and small (mice, rats) animal models for human-relevant insights
Data-Driven Outcomes: AI-powered analytics and customizable reporting for confident decision-making
